4Effect of domestic luteinizing hormone releasing hormone- analogue and low-dose norethindrone add-back therapy on reproductive hormone and lumbar bone mineral density in the treatment of endometriosis175-178
5Measurements of soluble intercellular adhesion molecule-1 and soluble interleukin-2 receptor and their significance in 23 patients with endometriosis179-180
6Clinical observation on the effects of mifepristone and gestrinone treatment for postoperative patients with severe pelvic endometriosis181-183
8Impact of serum E2 levels and the number of retrieved oocytes on clinical outcome of in vitro fertilization and embryo transfer187-190